Skip to the main content.
Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Turn Our Insights Into Your Impact

From early feasibility to commercialization, progress depends on the right decisions at the right time. Get confident in your next step with blogs, case studies, and expert insights that cut through complexity and move development forward.

 

Veranex News

3 min read

Veranex Announces Investment From Summit Partners to Form Comprehensive Concept-to-Commercialization MedTech Services Company

RALEIGH, N.C.; June 16, 2021 – Veranex today announced the formation of the first concept-to-commercialization global service provider dedicated to the medtech industry. Formed in partnership with global growth investor Summit Partners, the Veranex...

Read More

1 min read

Quartesian Signs Global Medical Technology Company to Multiyear Clinical Data Management Services Agreement

PRINCETON, N.J., April 13, 2021 — Quartesian, a multinational clinical research organization (CRO) serving the biopharmaceutical and medical device...

Read More

1 min read

Quartesian Announces Amyndas Partnership for COVID-19 Clinical Trial

PRINCETON, N.J., June 16, 2020 /PRNewswire/ — Quartesian, a multinational clinical research organization (CRO) serving the biopharmaceutical and...

Read More